description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGGTTTACACCAGCGAGTGAGGTCCCACTCTGTGGCCATGCCACCCTGGCTTCTGCAGCTGTGCTGTTTCACAAAATAAAAAACATGAATAGCACGCTCACGTTTGTCACTCTGAGTGGAGAACTAAGGGCCAGACGAGCAGAGGATGGCATCGTCCTGGACTTGCCTCTTTATCCAGCCCACCCCCAGGACTTCCATGAAGTAGAGGACTTGATAAAGACTGCCATAGGCAACACACTGGTCCAGGACATCTGTTATTCTCCAGATACCCAAAAGCTCCTCGTCCGCCTCAGTGACGTTTACAACAGGTCGTTTCTGGAGAACC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... PBLD(64081)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Aimin Li et al.
Oncotarget, 7(1), 524-537 (2015-11-26)
Recent accumulating genomic and proteomic data suggested that decreased expression of phenazine biosynthesis-like domain-containing protein (PBLD) was frequently involved in hepatocellular carcinoma (HCC). However, there is lack of systematical investigation focusing on its expression pattern, clinical relevance, and biological function.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU097771-20UG | 04061828588701 |
| EHU097771-50UG | 04061828354283 |